For the quarter ending 2026-03-31, ANVS has $16,243,703 in assets. $13,117,645 in debts. $14,219,081 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,219,081 | 19,532,338 | 15,286,399 | 17,130,286 |
| Prepaid expenses and other current assets | 2,024,622 | 1,549,287 | 1,902,562 | 4,324,285 |
| Total assets | 16,243,703 | 21,081,625 | 17,188,961 | 21,454,571 |
| Accounts payable | 5,275,668 | 2,590,516 | 2,112,026 | 974,311 |
| Accrued expenses | 7,514,977 | 1,044,859 | 1,621,771 | 1,830,813 |
| Total current liabilities | 12,790,645 | 3,635,375 | 3,733,797 | 2,805,124 |
| Warrant liability | 327,000 | 595,000 | 299,000 | 319,000 |
| Total liabilities | 13,117,645 | 4,230,375 | 4,032,797 | 3,124,124 |
| Common stock - 0.0001 par value, 70,000,000 shares authorized, 28,537,302 and 27,199,139 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 2,854 | 2,719 | 2,019 | 1,948 |
| Additional paid-in capital | 184,433,245 | 180,552,190 | 167,023,392 | 164,935,088 |
| Accumulated deficit | -181,310,041 | -163,703,659 | -153,869,247 | -146,606,589 |
| Total stockholders' equity | 3,126,058 | 16,851,250 | 13,156,164 | 18,330,447 |
| Total liabilities and stockholders' equity | 16,243,703 | 21,081,625 | 17,188,961 | 21,454,571 |
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS)